Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB
Clinical trial NCT05295212 · RECRUITING
Trial details
- NCT number
- NCT05295212
- Sponsor
- Hunan Province Tumor Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.